Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IONS
Stock Latest News
Ratings
Positive Outlook for Ionis Pharmaceuticals Driven by Strong Q2 Results and Promising Pipeline Developments
4d ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Reports Strong Earnings and Growth
4d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Hold Rating Amid Strong Performance and Future Uncertainties
5d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Q2 Performance and Promising Future Catalysts Justify Buy Rating
5d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $65 from $50 at H.C. Wainwright
5d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Financial Performance and Strategic Growth Drive Buy Rating
5d ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Reports Strong Q2 2025 Results
5d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Financial Performance and Promising Clinical Developments Drive Buy Rating
5d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Performance and Promising Future Drive Buy Rating Upgrade
5d ago
IONS
Premium
The Fly
Ionis upgraded to Overweight from Equal Weight at Morgan Stanley
5d ago
IONS
Premium
The Fly
Morgan Stanley upgrades Ionis to Overweight on Tryngolza momentum
5d ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Financial Performance and Promising Prospects Justify Buy Rating
5d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals raises FY25 revenue view to $825M-$850M from $725M-$750M
6d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals reports Q2 EPS 70c, consensus 16c
6d ago
IONS
Premium
The Fly
Barclays says Merck/AstraZeneca earnings neutral to Moderna, negative to Ionis
6d ago
AZN
MRK
Premium
Pre-Earnings
IONS Earnings this Week: How Will it Perform?
8d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals announces CHMP opinion recommending Tryngolza
11d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals publishes results of OASISplus study
15d ago
IONS
Premium
Ratings
Hold Rating on Ionis Pharmaceuticals Amid Uncertainty Over Olezarsen’s Pancreatitis Endpoint
19d ago
IONS
Premium
The Fly
Nike upgraded, Sportradar initiated: Wall Street’s top analyst calls
1M ago
H
SG
Premium
The Fly
Ionis Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
1M ago
IONS
Premium
Ratings
Cautious Optimism for Ionis Pharmaceuticals: Hold Rating Amid Awaited Olezarsen Data
1M ago
IONS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
